|
Research Interests:
Dr. Dacic is a surgical pathologist with subspecialty interest in lung transplantation, pulmonary and mediastinal pathology. Her research interests relate to molecular profiling of lung carcinoma and detection of tumor markers that have potential to be used clinically for diagnosis and prognostication of lung carcinoma.
Selected Publications:
View Dr. Dacic's publications on PubMed
Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007; 65(5):2345-50.
Gradowski JF, Mantha GS, Hunt JL, Dacic S. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs. Diagn Mol Pathol 2007; 16(2):87-90.
Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W, Siegfried JM, Yu J, Zhang L. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res 2007; 13(15):4336-4344.
Yue W, Sun QH, Dacic S, Landreneau R, Siegfried JM, Yu J, Zhang, L. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 2008; 29 (1); 84-92.
Striebel JM., Dacic S, Yousem SA. Gross Cystic Disease Fluid Protein – 15 (GCDFP-15) expression in primary lung adenocarcinoma. Am J Surg Pathol 2008; 32(3):426-32.
Chiosea S, Cagle P, Krasinskas A, Zander D, Mitchell K, Dacic S. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas. Mod Pathol 2008; 21 (6):742-7.
Dacic S, Kothmaier H, Land S, Shuai Y , Halbwedl I, Morbini P, Murer B, Comin CE, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle PT, HH. Prognostic significance of p16/CDKN2a deletion in pleural malignant mesotheliomas. Virchows Arch 2008 Dec;453(6):627-35.
Achcar R, Nikiforova M, Dacic S, Nicholson A,Yousem SA. MAML2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol 2009 Mar 5 Epub ahead of print]
Dacic S. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis. Exp Rev Mol Diagn 2007; 7 (1): 77-86.
Dacic S. Preneoplastic lesions of the lung carcinoma. Arch Path Lab Med 2008; 132(7):1073-78.
Dacic S. EGFR assays in lung cancer. Adv Anatom Pathol 2008; 15(4):241-7.
|
